Carlumab
From Infogalactic: the planetary knowledge core
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Human |
Target | MCP-1 |
Identifiers | |
CAS Number | 915404-94-3 ![]() |
ATC code | none |
Chemical data | |
Formula | C6442H9966N1706O2018S40 |
Molecular mass | 144.88 kg/mol |
![]() ![]() |
Carlumab is a human monoclonal antibody designed for oncology and immune indications.[1][2]
Carlumab was developed by Johnson & Johnson.
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
<templatestyles src="Asbox/styles.css"></templatestyles>
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Chemical articles having calculated molecular weight overwritten
- Drugs that are a monoclonal antibody
- Articles without EBI source
- Chemicals that do not have a ChemSpider ID assigned
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Johnson & Johnson
- Monoclonal antibody stubs
- Antineoplastic and immunomodulating drug stubs